For example, studies focusing on breast cancer patients and their families estimated the penetrance of BRCA1 and BRCA2 mutations by age 70 to be 65–85% and 70–84%, respectively [21,38,39]. This evidence concerns the gene BRCA1 and breast carcinoma.